JPH05286845A - Cosmetic for preventing skin ageing - Google Patents
Cosmetic for preventing skin ageingInfo
- Publication number
- JPH05286845A JPH05286845A JP4109137A JP10913792A JPH05286845A JP H05286845 A JPH05286845 A JP H05286845A JP 4109137 A JP4109137 A JP 4109137A JP 10913792 A JP10913792 A JP 10913792A JP H05286845 A JPH05286845 A JP H05286845A
- Authority
- JP
- Japan
- Prior art keywords
- dha
- cosmetic
- epa
- skin
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、化粧料に関し、更に詳
細には、優れた皮膚老化防止作用、肌荒れ改善作用等を
有する皮膚老化防止用化粧料に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a cosmetic composition, and more particularly to a cosmetic composition for preventing skin aging, which has excellent effects of preventing skin aging, improving skin roughness and the like.
【0002】[0002]
【従来の技術】従来、肌荒れ改善や皮膚老化防止のため
に用いられてきた薬効成分としては、アラントイン、ア
ロエ抽出物、人参抽出物、胎盤抽出物、牛血液除蛋白物
および発酵代謝物等が知られている。しかしながら、こ
れらの薬効成分を含む化粧料では、十分な効果を得るこ
とができず、より優れた作用を有する化粧料の開発が望
まれていた。2. Description of the Prior Art Medicinal ingredients that have been conventionally used to improve skin roughness and prevent skin aging include allantoin, aloe extract, ginseng extract, placenta extract, bovine blood deproteinate and fermented metabolites. Are known. However, cosmetics containing these medicinal components cannot obtain sufficient effects, and development of cosmetics having more excellent action has been desired.
【0003】一方、抗炎症作用、抗アレルギー作用
(「油化学」,37, p9, (1988)、「油化学」,40,
p203, (1991))等を有する化合物として、エイコサ
ペンタエン酸(以下、「EPA」と略称する)及びドコ
サヘキサエン酸(以下、「DHA」と略称する)を含有
する油脂が注目されている。 このEPAやDHAは魚
油中に多く含まれており、血栓防止活性や、動脈硬化防
止活性などの薬理効果を有することが古くから知られて
いた。 また、近年では、局所投与した場合、血管運動
および血管拡張効果があることが見出された(特開平2
−48528号)。On the other hand, anti-inflammatory action and anti-allergic action ("Oil Chemistry", 37, p9, (1988), "Oil Chemistry", 40,
As a compound having p203, (1991)) or the like, an oil and fat containing eicosapentaenoic acid (hereinafter abbreviated as “EPA”) and docosahexaenoic acid (hereinafter abbreviated as “DHA”) has been attracting attention. It has long been known that EPA and DHA are contained in fish oil in a large amount and have pharmacological effects such as thrombus prevention activity and arteriosclerosis prevention activity. Further, in recent years, it has been found that local administration has a vasomotor and vasodilatory effect (Japanese Patent Application Laid-Open No. HEI 2
-48528).
【0004】[0004]
【発明が解決しようとする課題】本発明者らは、EPA
やDHAの有する上記作用に着目し、これを化粧料、特
に皮膚老化防止を目的とする化粧料に配合することを試
みた。 しかし、EPAやDHAもしくはこれを含有す
る油脂類を単独に配合した場合の皮膚老化防止効果や肌
荒れ改善効果は十分なものとはいえず、また他の基剤等
の影響により、これらの本来有する効果が十分に発揮さ
れ得ないのが実情であった。DISCLOSURE OF THE INVENTION The present inventors have found that EPA
Attention was paid to the above-mentioned action of DHA and DHA, and an attempt was made to mix them with a cosmetic, particularly a cosmetic for the purpose of preventing skin aging. However, it cannot be said that the effect of preventing skin aging and the effect of improving skin roughness when EPA, DHA or oils and fats containing them are blended alone are sufficient, and due to the influence of other bases etc. The reality is that the effects cannot be fully exerted.
【0005】さらに、より高い効果を得る目的でEPA
及び/またはDHAもしくはこれを含有する油脂類を高
濃度で配合した場合の作用効果にも限界があり、逆に、
これら化合物自体の有する特有の色や臭いの発生により
配合量や剤型等製品面における制限も生じてくるといっ
た問題もあった。Further, for the purpose of obtaining a higher effect, EPA
And / or DHA or fats and oils containing this has a limited effect when mixed at a high concentration, and conversely,
There is also a problem that due to the generation of unique colors and odors possessed by these compounds themselves, there is a limitation in terms of product amount and formulation.
【0006】[0006]
【課題を解決するための手段】前記実情に鑑み、本発明
者等は、EPA及び/またはDHAもしくはこれを含有
する油脂類の有する作用を十分に引き出すべく鋭意研究
を行った。 そしてその結果、これらと特定の成分とを
組合せることにより、優れた皮膚老化防止効果、肌荒れ
改善効果が安定且つ相乗的に発揮されることを見出し本
発明を完成した。In view of the above-mentioned circumstances, the inventors of the present invention have conducted diligent research so as to sufficiently bring out the action of EPA and / or DHA or fats and oils containing the same. As a result, they have found that, by combining these with a specific component, an excellent effect of preventing skin aging and an effect of improving rough skin can be stably and synergistically achieved, and the present invention has been completed.
【0007】すなわち本発明は、EPA及び/またはD
HAもしくはこれを含有する油脂類と、センブリエキ
ス、カンファ、ニコチン酸もしくはその誘導体、ニンニ
クエキス、セファランチンおよびトウガラシチンキから
選ばれる成分の一種または二種以上とを含有する皮膚老
化防止用化粧料を提供するものである。That is, the present invention relates to EPA and / or D
Provided is a cosmetic composition for preventing skin aging, which comprises HA or oils or fats containing the same, and one or more components selected from senburi extract, camphor, nicotinic acid or its derivative, garlic extract, cepharanthin and capsicum tincture. To do.
【0008】EPA及び/またはDHAは、前記したよ
うに魚油、例えば、イワシ油、サンマ油、ニシン油、サ
バ油、タラ油等の中に多く含まれる不飽和脂肪酸であ
る。例えば、イワシ油はEPAを約16%、DHAを約
8.4%、サンマ油はEPAを約4.9%、DHAを約1
0.5%、サバ油はEPAを約8.1%、DHAを約1
0.6%、タラ油はEPAを約13.3%、DHAを約1
3.7%それぞれ含んでいる。As described above, EPA and / or DHA are unsaturated fatty acids contained in a large amount in fish oils such as sardine oil, saury oil, herring oil, mackerel oil and cod oil. For example, sardine oil contains about 16% EPA, about 8.4% DHA, and saury oil contains about 4.9% EPA and about 1 DHA.
0.5%, mackerel oil about EPA 8.1%, DHA about 1
0.6%, cod oil EPA about 13.3%, DHA about 1
3.7% each is included.
【0009】本発明において用いるEPA及び/または
DHAもしくはこれを含有する油脂類は、魚油から常法
により分離、精製したものを利用しても良いが、単に魚
油を抽出することにより得られる、EPA及び/または
DHAを含有する油脂を利用しても良い。魚油を抽出す
る方法は特に限定されず、臨界ガス抽出法、分子蒸留
法、液体クロマトグラフ法等の油脂を抽出する方法とし
て公知の方法を採用することができる。The EPA and / or DHA or fats and oils containing the same used in the present invention may be obtained by separating and purifying fish oil by a conventional method, but EPA obtained by simply extracting fish oil. Oils and fats containing DHA and / or DHA may be used. The method for extracting fish oil is not particularly limited, and a known method such as a critical gas extraction method, a molecular distillation method, a liquid chromatography method, or the like can be adopted as a method for extracting fats and oils.
【0010】EPA及び/またはDHAを含有する油脂
は、そのまま本発明の化粧料に配合しても、また、更に
水蒸気蒸留、活性炭処理、酸性白土処理等によって精製
したものを利用しても良い。The fats and oils containing EPA and / or DHA may be blended as they are with the cosmetic of the present invention, or may be refined by steam distillation, activated carbon treatment, acid clay treatment or the like.
【0011】本発明の化粧料におけるEPA及び/また
はDHAの含有量は、0.0001〜10重量%(以下
単に「%」で示す)であり、より好ましくは0.01〜
5%である。 EPA及び/またはDHAの純度の低い
油脂を利用する場合は、EPA及び/またはDHAの含
有量として上記範囲内であれば良い。The content of EPA and / or DHA in the cosmetic composition of the present invention is 0.0001 to 10% by weight (hereinafter simply referred to as "%"), and more preferably 0.01 to 10.
5%. When using a low-purity oil or fat of EPA and / or DHA, the content of EPA and / or DHA may be within the above range.
【0012】EPA及び/またはDHAの含有量が0.
0001%より少ないと十分な効果が得られないことが
あり、また、10%を越えて配合してもそれ以上の効果
の増大は見られず、かえって着色、臭いの発生や、剤型
によっては沈澱が生じる等、製品面での問題が生じる場
合がある。The content of EPA and / or DHA is 0.
If it is less than 0001%, a sufficient effect may not be obtained, and even if it exceeds 10%, no further increase in the effect is observed. Instead, depending on the coloring, the generation of odor, and the dosage form. Problems such as precipitation may occur on the product side.
【0013】一方、本発明において他の必須成分である
センブリエキス、カンファ、ニコチン酸もしくはその誘
導体、ニンニクエキス、セファランチンおよびトウガラ
シチンキなどの成分(以下、「第二成分」と総称する)
は、いずれも、従来から化粧料に配合されている成分で
ある。On the other hand, in the present invention, other essential components such as assembly extract, camphor, nicotinic acid or a derivative thereof, garlic extract, cepharanthin and capsicum tincture (hereinafter collectively referred to as "second component").
Are all components that have been conventionally blended in cosmetics.
【0014】これらの第二成分のうち、センブリエキ
ス、カンファ、ニンニクエキス、セファランチンおよび
トウガラシチンキは天然物中から抽出により得られる物
質であ、る。Among these second components, citrus extract, camphor, garlic extract, cepharanthin and capsicum tincture are substances obtained by extraction from natural products.
【0015】すなわち、センブリエキスは、センブリ
[Swertia japonica Makino (Gentianaceae)]の開花
期の全草からエタノール、精製水、またはこれらの混液
で抽出して得られるエキスであり、カンファは、クスノ
キ[Cinnamomum camphora Linne(Lauraceae)]より得
られるテルペンケトンである。[0015] That is, the assembly extract is an extract obtained by extracting whole plants of the assembly [Swertia japonica Makino (Gentianaceae)] at the flowering stage with ethanol, purified water, or a mixture thereof, and camphor is a camphor tree [Cinnamomum]. camphora Linne (Lauraceae)].
【0016】また、ニンニクエキスは、ニンニク(Alli
um scordoplasm L.またはAllium sativum L.)の鱗茎か
ら精製水、無水エタノール、プロピレングリコール、
1,3−ブチレングリコールまたはこれらの混液にて抽
出して得られるエキスである。The garlic extract is garlic (Alli
um scordoplasm L. or Allium sativum L.) bulbs purified water, absolute ethanol, propylene glycol,
It is an extract obtained by extraction with 1,3-butylene glycol or a mixture thereof.
【0017】更に、セファランチンは、ツヅラフジ科の
植物タマサキツヅラフジ(Stephaura cepharantha Haya
ta)の根より抽出して得られるものである。更にまた、
トウガラシチンキは、トウガラシ[Capsicum annuum Li
nne(Solanaceae)]またはその変種の果実をエタノー
ルで浸出して得られるチンキ剤である。なお、いずれの
場合も抽出方法、精製処理方法については特に制約はな
い。[0017] Further, cepharanthin is a plant belonging to the family Cistancheaceae, Stephaura cepharantha Haya.
It is obtained by extracting from the root of ta). Furthermore,
Capsicum annuum Li
nne (Solanaceae)] or a variant thereof is a tincture obtained by leaching with ethanol. In any case, there is no particular restriction on the extraction method and the purification treatment method.
【0018】一方、ニコチン酸およびその誘導体は、ビ
タミンBの一種であり、牛肝臓または米糠等から抽出し
て得られるものでも合成によって得られるものでも良
く、ニコチン酸の他、ニコチン酸アミド、ニコチン酸D
L−α−トコフェロール、ニコチン酸メチル等のニコチ
ン酸誘導体が例示される。On the other hand, nicotinic acid and its derivatives are a kind of vitamin B, and may be those obtained by extraction from beef liver, rice bran or the like, or those obtained by synthesis. In addition to nicotinic acid, nicotinic acid amide, nicotine Acid D
Illustrative are nicotinic acid derivatives such as L-α-tocopherol and methyl nicotinate.
【0019】これら第二成分の本発明化粧料中の含有量
は、一般には0.0001〜5%、好ましくは0.001
〜3%である。これら成分の含有量が0.0001%よ
り少ない場合は、十分な効果が得られないことがあり、
また、5%を超えて配合しても効果がほぼ一定となり、
その増大は見られない。The content of these second components in the cosmetic of the present invention is generally 0.0001 to 5%, preferably 0.001.
~ 3%. If the content of these components is less than 0.0001%, sufficient effects may not be obtained,
In addition, the effect becomes almost constant even if it exceeds 5%,
No increase is seen.
【0020】本発明の皮膚老化防止用化粧料は、常法に
従い、必須成分であるEPA及び/またはDHAもしく
はこれを含有する油脂類と、他の必須成分である第二成
分とを通常の化粧料として知られる種々の形態の基剤に
配合して調製することができる。The cosmetic for preventing skin aging of the present invention comprises, in accordance with a conventional method, EPA and / or DHA as essential components or oils and fats containing the same, and a second component as another essential component. It can be prepared by blending with various types of bases known as ingredients.
【0021】化粧料の形態の例としては、特に限定され
ず、例えば、乳液、クリーム、化粧水、パック、分散
液、洗浄料等の化粧品とすることができ、化粧料の基剤
としては、これら化粧料の形態に応じた基剤、例えば、
精製水、低級アルコール類、多価アルコール類、油脂
類、界面活性剤、各種美容成分、紫外線吸収剤、増粘
剤、色素、防腐剤、香料等を用いることができる。The form of the cosmetic is not particularly limited, and may be cosmetics such as emulsion, cream, lotion, pack, dispersion, and cleaning agent. The base of the cosmetic is Bases depending on the form of these cosmetics, for example,
Purified water, lower alcohols, polyhydric alcohols, oils and fats, surfactants, various cosmetic ingredients, ultraviolet absorbers, thickeners, pigments, preservatives, fragrances and the like can be used.
【0022】[0022]
【実施例】次に、実施例を挙げ本発明を更に詳しく説明
するが、本発明はこれらになんら制約されるものではな
い。EXAMPLES Next, the present invention will be described in more detail by way of examples, which should not be construed as limiting the invention thereto.
【0023】実 施 例 1〜4 クリーム:下記表1に示す組成のクリームを製造し、肌
荒れ改善効果を調べた。この結果も表1に示す。なお、
クリームの製法および評価方法は次のとおりである。Examples 1 to 4 Cream: A cream having the composition shown in Table 1 below was produced, and the effect of improving rough skin was examined. The results are also shown in Table 1. In addition,
The cream production method and evaluation method are as follows.
【0024】(製 法) A. 成分(8)、(10)〜(14)を加熱混合し、70℃に保
つ。 B. 成分(1)〜(7)および(9)を加熱混合し、70℃に保
つ。 C. 上記Bを先のAに加えて混合し、均一に乳化する。 D. 上記Cを冷却後、(15)を加え、均一に混合してクリ
ームを得た。(Production Method) A. Components (8) and (10) to (14) are mixed by heating and kept at 70 ° C. B. Ingredients (1)-(7) and (9) are mixed by heating and kept at 70 ° C. C. Add the above B to the above A, mix, and uniformly emulsify. D. After cooling the above C, (15) was added and uniformly mixed to obtain a cream.
【0025】(評価方法)健常な男性135名をパネル
とし、1群15名として、顔面半面に実施例1〜4又は
比較例1〜5のクリームを、他の半面に比較例6のクリ
ームを、それぞれ1日1回、2週間塗布した。2週間
後、顔面皮膚レプリカを採取し、下記に示す基準により
評価した。得られた実施例1〜4、比較例1〜5のクリ
ーム塗布部位のレプリカのスコアから比較例6のクリー
ム塗布部位のレプリカのスコアを引いた値を肌荒れ改善
度とした。なお、パネルには、試験開始前のスコアが1
又は2の男性を選んだ。(Evaluation method) 135 healthy men were used as a panel, and 15 people per group, the creams of Examples 1 to 4 or Comparative Examples 1 to 5 on one half of the face, and the cream of Comparative Example 6 on the other half. , Once a day for 2 weeks. Two weeks later, a facial skin replica was collected and evaluated according to the criteria shown below. The value obtained by subtracting the score of the replica of the cream-applied portion of Comparative Example 6 from the obtained score of the replica of the cream-applied portion of Examples 1 to 4 and Comparative Examples 1 to 5 was taken as the degree of skin roughening improvement. In addition, the score before the start of the test is 1 on the panel
Or I chose 2 men.
【0026】 肌状態スコア: [スコア] [ 状 態 ] 1 肌の皮溝が不鮮明であり、角質のはがれが認められる。 2 肌の皮溝がやや不鮮明であるかまたは一方向性が強い。 3 肌の皮溝は認められるが、浅いかまたは一方向性がやや強い。 4 肌の皮溝が認められるかまたはやや網目状である。 5 肌の皮溝がはっきり認められるかまたはきれいな網目状である。Skin condition score: [Score] [Situation] 1 Skin crevices on the skin are not clear, and exfoliation of keratin is observed. 2 The skin groove on the skin is slightly blurred or unidirectional. 3 Skin groove is observed, but it is shallow or slightly unidirectional. 4 Skin crevices are observed or are slightly mesh-like. 5 Skin crevices are clearly visible or have a clean mesh.
【0027】(結果)(Result)
【表1】 [Table 1]
【0028】以上の結果から、DHAと第二成分とを配
合した本発明化粧料は、DHAまたは第二成分を単独で
配合した場合に比べて、顕著な肌荒れ改善効果を奏する
ことが明らかである。From the above results, it is clear that the cosmetic of the present invention containing DHA and the second component exhibits a remarkable effect of improving rough skin, as compared with the case where DHA or the second component is added alone. ..
【0029】実 施 例 5〜6 クリーム:表2に示す組成および下記製法でクリームを
調製し、下記方法でその皮膚老化防止作用を調べた。Examples 5-6 Cream: A cream was prepared by the composition shown in Table 2 and by the following production method, and its skin aging-preventing action was examined by the following method.
【0030】 * 栗田工業(株)製 ** トウガラシ中切のエチルアルコール浸出物 ***ニコチン酸アミド(有機合成薬品社製)[0030] * Kurita Water Industries Co., Ltd. ** Pepper sliced ethyl alcohol leachate *** Nicotinic acid amide (Organic Synthetic Chemicals)
【0031】(製 法) A. 成分(9)〜(11)および(13)を加熱混合し、70℃に
保つ。 B. 成分(1)〜(8)を加熱混合し、70℃に保つ。 C. 上記Bを先のAに加えて混合し、均一に乳化する。 D. 上記Cを冷却後、成分(12)を加え、均一に混合して
クリームを得た。(Production Method) A. Components (9) to (11) and (13) are mixed by heating and kept at 70 ° C. B. Components (1) to (8) are mixed by heating and kept at 70 ° C. C. Add the above B to the above A, mix, and uniformly emulsify. D. After cooling the above C, the component (12) was added and uniformly mixed to obtain a cream.
【0032】(評価方法)26〜52歳の女性15名を
パネルとし、毎日朝と夜の2回、12週間にわたって洗
顔後に被験クリームの適量を顔面に塗布した。塗布によ
る美肌効果および皮膚老化防止効果を下記の基準によっ
て評価した。(Evaluation method) A panel of 15 women aged 26 to 52 was applied twice daily in the morning and evening twice for 12 weeks, and an appropriate amount of the test cream was applied to the face. The effect of beautiful skin and the effect of preventing skin aging by application were evaluated according to the following criteria.
【0033】美肌効果: [評 価] [ 内 容 ] 有 効 肌のくすみが目立たなくなった。 やや有効 肌のくすみがやや目立たなくなった。 無 効 使用前と変化なし。Skin beautifying effect: [Evaluation] [Content] Effectiveness The dullness of the skin became inconspicuous. Somewhat effective The dullness of the skin has become a little less noticeable. No effect No change from before use.
【0034】皮膚老化防止効果: [評 価] [ 内 容 ] 有 効 肌のはり、つやが改善された。 やや有効 肌のはり、つやがやや改善された。 無 効 使用前と変化なし。Skin Aging Preventive Effect: [Evaluation] [Content] Effectiveness The scalp and gloss of the skin were improved. Slightly effective Skin tone and gloss were slightly improved. No effect No change from before use.
【0035】(結果)結果を表3に示す。(Results) The results are shown in Table 3.
【0036】 [0036]
【0037】表3の結果より明らかな如く、実施例5及
び6のクリームは肌の「つや」、「はり」の喪失・「く
すみ」等の発生の防止、改善に有効であり、皮膚老化防
止効果が認められた。As is clear from the results shown in Table 3, the creams of Examples 5 and 6 are effective in preventing and improving the loss of "luster", "beam" and "dullness" of the skin, and the prevention of skin aging. The effect was recognized.
【0038】実 施 例 7 化 粧 水 : <処方> (%) (1)ポリオキシエチレン硬化ヒマシ油(60E.O.) 1.0 (2)エチルアルコール 10.0 (3)防腐剤 0.1 (4)香料 適 量 (5)イワシ抽出油脂 1.0 (6)センブリエキス* 0.5 (7)ソルビトール(70%水溶液) 3.0 (8)ピロリドンカルボン酸ナトリウム 3.0 (9)精 製 水 残 量 * スコルチアニン[一丸ファルコス(株)製]Example 7 Modified cosmetic water: <Prescription> (%) (1) Polyoxyethylene hydrogenated castor oil (60 E.O.) 1.0 (2) Ethyl alcohol 10.0 (3) Preservatives 0.0. 1 (4) Perfume proper amount (5) Sardine extract fats and oils 1.0 (6) Assemblage extract * 0.5 (7) Sorbitol (70% aqueous solution) 3.0 (8) Sodium pyrrolidonecarboxylate 3.0 (9) Purified water balance * Scortianine [manufactured by Ichimaru Falcos Co., Ltd.]
【0039】(製 法) A. 成分(1)〜(5)を加熱、混合溶解する。 B. 成分(6)〜(9)を加熱、混合溶解する。 C. 上記AとBを混合して均一とし、化粧水を得た。(Production Method) A. Components (1) to (5) are heated and mixed to dissolve. B. Components (6) to (9) are heated and mixed to dissolve. C. The above A and B were mixed to make uniform, and lotion was obtained.
【0040】実 施 例 8 乳液: <処方> (%) (1) ポリオキシエチレンソルビタ 1.0 ンモノステアレート(10E.O.) (2) ポリオキシエチレンソルビッ 0.5 トテトラオレエート(60E.O.) (3) グリセリンモノステアレート 1.0 (4) ステアリン酸 0.5 (5) ベヘニルアルコール 0.5 (6) 精製アボガド油 4.0 (7) トリ2−エチルヘキサン酸グ 4.0 リセリン (8) 防腐剤 0.1 (9) DHA* 1.0 (10)ウィッチヘーゼルエキス 0.1 (11)キサンタンガム(2%水溶液) 7.0 (12)1,3−ブチレングリコール 5.0 (13)カンファ** 1.0 (14)セファランチン*** 1.0 (15)精製水 残 量 (16)香料 適 量 * Serdary Research Lab.Inc.製 ** カンファ[高砂香料工業(株)製] ***セファランチン(丸善製薬社製)Example 8 Emulsion: <Prescription> (%) (1) Polyoxyethylene sorbita 1.0 Monostearate (10E.O.) (2) Polyoxyethylene sorbit 0.5 Totetraole (60 E.O.) (3) Glycerin monostearate 1.0 (4) Stearic acid 0.5 (5) Behenyl alcohol 0.5 (6) Refined avocado oil 4.0 (7) Tri-2-ethylhexanoic acid 4.0 Glycerin (8) Preservative 0.1 (9) DHA * 1.0 (10) Witch hazel extract 0.1 (11) Xanthan gum (2% aqueous solution) 7.0 (12) 1,3-butylene Glycol 5.0 (13) Camphor ** 1.0 (14) Cepharanthin *** 1.0 (15) Purified water Remaining amount (16) Fragrance Suitable amount * Made by Serdary Research Lab. Inc. ** Camphor [Takasago Fragrance Industrial Co., Ltd.] *** Cepharanthin (Maruzen Pharmaceutical Co., Ltd.)
【0041】( 製 法 ) A. 成分(10)〜(15)を加熱混合し、70℃に保つ。 B. 成分(1)〜(9)を加熱混合し、70℃に保つ。 C. 上記Bを先のAに加えて混合し、均一に乳化する。 D. 上記Cを冷却後、(16)を加え、均一に混合して乳液
を得た。(Production method) A. Components (10) to (15) are mixed by heating and kept at 70 ° C. B. Components (1) to (9) are mixed by heating and kept at 70 ° C. C. Add the above B to the above A, mix, and uniformly emulsify. D. After cooling the above C, (16) was added and uniformly mixed to obtain an emulsion.
【0042】実 施 例 9 軟 膏 : <処方> (%) (1) ステアリン酸 18.0 (2) セタノール 4.0 (3) トリエタノールアミン 2.0 (4) グリセリン 5.0 (5) サンマ抽出油脂 2.0 (6) ニンニクエキス* 1.0 (7) 精製水 残 量 * レイソーゲン[武山ガーリック化学(株)製]Example 9 Ointment: <Prescription> (%) (1) Stearic acid 18.0 (2) Cetanol 4.0 (3) Triethanolamine 2.0 (4) Glycerin 5.0 (5) Oil and fat extracted from saury 2.0 (6) Garlic extract * 1.0 (7) Residual amount of purified water * Reisogen [Takeyama Garlic Chemical Co., Ltd.]
【0043】(製 法) A. 成分(3)、(4)及び(7)の一部を加熱混合
し、75℃に保つ。 B. 成分(1)、(2)および(5)を加熱混合し、7
5℃に保つ。 C. 上記Aを先のBに徐々に加える。 D. 上記Cを冷却しながら(7)の残部で溶解した
(6)を加え、軟膏を得た。(Production Method) A. A part of the components (3), (4) and (7) is mixed by heating and kept at 75 ° C. B. Heat-mix components (1), (2) and (5), and
Keep at 5 ° C. C. Gradually add A above to B above. D. While cooling above C, (6) dissolved in the rest of (7) was added to obtain an ointment.
【0044】[0044]
【発明の効果】以上詳述した如く、本発明によりEPA
及び/またはDHAもしくはこれを含有する油脂類を配
合し、安定で優れた皮膚老化防止効果、肌荒れ改善効果
を有する化粧料が得られる。As described in detail above, according to the present invention, EPA
And / or DHA or fats and oils containing the same is blended to obtain a cosmetic which is stable and has an excellent effect of preventing skin aging and an effect of improving rough skin.
Claims (1)
サヘキサエン酸もしくはこれを含有する油脂類と、セン
ブリエキス、カンファ、ニコチン酸もしくはその誘導
体、ニンニクエキス、セファランチンおよびトウガラシ
チンキから選ばれる成分の一種または二種以上とを含有
する皮膚老化防止用化粧料。1. Eicosapentaenoic acid and / or docosahexaenoic acid or fats and oils containing the same, and one or more components selected from cembly extract, camphor, nicotinic acid or derivatives thereof, garlic extract, cepharanthin and capsicum tincture. A cosmetic for preventing skin aging containing and.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10913792A JP3197938B2 (en) | 1992-04-03 | 1992-04-03 | Cosmetic for preventing skin aging |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10913792A JP3197938B2 (en) | 1992-04-03 | 1992-04-03 | Cosmetic for preventing skin aging |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH05286845A true JPH05286845A (en) | 1993-11-02 |
JP3197938B2 JP3197938B2 (en) | 2001-08-13 |
Family
ID=14502535
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10913792A Expired - Lifetime JP3197938B2 (en) | 1992-04-03 | 1992-04-03 | Cosmetic for preventing skin aging |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3197938B2 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11508281A (en) * | 1996-04-23 | 1999-07-21 | ザ、プロクター、エンド、ギャンブル、カンパニー | How to adjust the appearance of skin with Vitamin B compounds |
US6423325B1 (en) * | 1999-07-30 | 2002-07-23 | Conopco, Inc. | Skin care composition |
FR2850580A1 (en) * | 2003-02-04 | 2004-08-06 | Innadev Pharm | Composition for oral or topical treatment of veruccas, keratosis or other skin disorders e.g. acne, comprising a mixture of plants, plant extracts and vegetable and/or animal oils rich in polyunsaturated fatty acids |
JP2005529728A (en) * | 2002-06-18 | 2005-10-06 | マーテック・バイオサイエンシーズ・コーポレーション | Stable emulsion of oil in aqueous solution and process for its production |
WO2010119955A1 (en) * | 2009-04-17 | 2010-10-21 | ロート製薬株式会社 | Agent for preventing, inhibiting, or ameliorating skin aging due to buildup of advanced glycation end products |
JP2010248148A (en) * | 2009-04-17 | 2010-11-04 | Rohto Pharmaceut Co Ltd | Breakdown agent of advanced glycation end product |
WO2019042796A1 (en) * | 2017-08-30 | 2019-03-07 | Unilever N.V. | A personal care composition |
-
1992
- 1992-04-03 JP JP10913792A patent/JP3197938B2/en not_active Expired - Lifetime
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11508281A (en) * | 1996-04-23 | 1999-07-21 | ザ、プロクター、エンド、ギャンブル、カンパニー | How to adjust the appearance of skin with Vitamin B compounds |
JP2002212053A (en) * | 1996-04-23 | 2002-07-31 | Procter & Gamble Co:The | Method for regulating skin appearance with vitamin b3 compound |
US6423325B1 (en) * | 1999-07-30 | 2002-07-23 | Conopco, Inc. | Skin care composition |
JP2005529728A (en) * | 2002-06-18 | 2005-10-06 | マーテック・バイオサイエンシーズ・コーポレーション | Stable emulsion of oil in aqueous solution and process for its production |
JP2006305569A (en) * | 2002-06-18 | 2006-11-09 | Martek Biosciences Corp | Stable emulsion of oil in aqueous solution and method for producing same |
US8529979B2 (en) | 2002-06-18 | 2013-09-10 | Dsm Ip Assets B.V. | Stable emulsions of oils in aqueous solutions and methods for producing same |
FR2850580A1 (en) * | 2003-02-04 | 2004-08-06 | Innadev Pharm | Composition for oral or topical treatment of veruccas, keratosis or other skin disorders e.g. acne, comprising a mixture of plants, plant extracts and vegetable and/or animal oils rich in polyunsaturated fatty acids |
WO2010119955A1 (en) * | 2009-04-17 | 2010-10-21 | ロート製薬株式会社 | Agent for preventing, inhibiting, or ameliorating skin aging due to buildup of advanced glycation end products |
JP2010248148A (en) * | 2009-04-17 | 2010-11-04 | Rohto Pharmaceut Co Ltd | Breakdown agent of advanced glycation end product |
WO2019042796A1 (en) * | 2017-08-30 | 2019-03-07 | Unilever N.V. | A personal care composition |
CN111050738A (en) * | 2017-08-30 | 2020-04-21 | 荷兰联合利华有限公司 | Personal care compositions |
Also Published As
Publication number | Publication date |
---|---|
JP3197938B2 (en) | 2001-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20060093689A1 (en) | Skin cosmetics | |
JP3635081B2 (en) | Whitening agents, antioxidants, collagenase activity inhibitors, hyaluronidase activity inhibitors, anti-aging agents, external preparations for skin, cosmetics and foods | |
JP2002020242A (en) | Hair care preparation composition | |
JP2006052198A (en) | Deodorant, deodorant preparation and method of deodorizing treatment of fiber | |
JP2006052198A5 (en) | ||
JP3586321B2 (en) | Cosmetics | |
JPH09241146A (en) | Skin external agent | |
CN106635563A (en) | Weak acid crystal soap for skin health and purification | |
JP3197938B2 (en) | Cosmetic for preventing skin aging | |
JP3170700B2 (en) | Cosmetic for preventing skin aging | |
JPH09131393A (en) | Deodorant, deodorizing composition, and deodorizing cosmetic | |
JP2001192328A (en) | Emulsified cosmetic | |
JPH06336422A (en) | External agent for skin | |
JP4754834B2 (en) | Cosmetics | |
JP2001302483A (en) | Deodorant | |
JP2003313113A (en) | Hair grower | |
JPH09227334A (en) | Agent containing amber component | |
JPH0665045A (en) | Skin external preparation | |
JP5341289B2 (en) | Masking agent and cosmetic containing the same | |
JP2005213202A (en) | Antioxidant, anti-aging agent and antiinflammatory agent, and skin cosmetic | |
JP3382148B2 (en) | External preparation for head | |
JPH05286846A (en) | Cosmetic for preventing skin ageing | |
JP3382149B2 (en) | External preparation for head | |
JP2021113172A (en) | Peptidyl arginine deiminase 1 expression promoter | |
JP2855274B2 (en) | Hair restoration |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120608 Year of fee payment: 11 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120608 Year of fee payment: 11 |